Market Analysis and Price Projections for NDC 69367-0362
Understanding the NDC Code
The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product. For the NDC 69367-0362, here is a breakdown of what each segment means:
- Labeler Code: The first segment (69367) is assigned by the FDA and identifies the labeler, which is the firm that manufactures, repacks, or relabels the drug.
- Product Code: The second segment identifies a specific strength, dosage form, and formulation for the particular firm.
- Package Code: The third segment identifies the package sizes and types[1].
Drug Identification
The NDC 69367-0362 corresponds to a specific formulation and packaging of Pregabalin, a medication used for various conditions such as epilepsy, neuropathic pain, and anxiety disorders. Pregabalin is manufactured and distributed by Westminster Pharmaceuticals, LLC[5].
Market Trends and Price Increases
General Trends in Prescription Drug Prices
Prescription drug prices, including those for Pregabalin, often experience significant increases, particularly in January and July of each year. According to recent data, the average price increase for prescription drugs in January 2022 was nearly $150 per drug (a 10% increase), and in July 2022, it was $250 (a 7.8% increase)[2].
Specific Price Trends for Pregabalin
For Pregabalin, specifically the NDC 69367-0330 (a similar formulation), price trends show variability over recent months:
- In December 2024, the price per unit was $0.06216.
- In November 2024, it was $0.05286.
- In October 2024, it increased to $0.07441.
- This fluctuation indicates that prices can change frequently based on market conditions and other factors[5].
Price Projections
Historical Context
Given the historical data, it is reasonable to expect that prices for Pregabalin could continue to fluctuate. Here are some key points to consider for price projections:
- Seasonal Increases: Prices tend to increase in January and July, so it is likely that the price for NDC 69367-0362 will follow this trend.
- Market Competition: The presence of generic versions of Pregabalin can influence pricing. As generics become more prevalent, brand-name prices may adjust to remain competitive.
- Inflation and Economic Factors: General inflation rates and economic conditions can also impact drug prices. For instance, the Consumer Price Index (CPI-U) increased by 8.5% between July 2021 and July 2022, which can influence drug price increases[2].
Projected Price Changes
Based on these factors, here are some possible scenarios for price projections:
- Short-Term Projections: For the next few months, prices might continue to fluctuate within a narrow range, potentially increasing by 5-10% in January 2025, following the historical trend.
- Long-Term Projections: Over the next year, if the trend of significant price increases in January and July continues, we could see an average annual increase of around 10-15% for Pregabalin.
Impact of Generic Competition
The introduction and increased availability of generic versions of Pregabalin can significantly impact the pricing of the brand-name version. As seen with other drugs, the sales of generics can reduce the market share and pricing power of brand-name drugs. For example, the sales of generic erlotinib in the NSCLC market are expected to reach $77 million by 2025, significantly impacting the sales of the patented version[4].
Conclusion on Market Analysis and Price Projections
The market analysis for NDC 69367-0362 suggests that prices will likely continue to be influenced by seasonal increases, market competition, and broader economic factors. Here are the key takeaways:
- Seasonal Price Increases: Expect significant price increases in January and July.
- Market Competition: Generic competition will play a crucial role in pricing.
- Economic Factors: General inflation and economic conditions will influence price changes.
Key Takeaways
- NDC Code Breakdown: The NDC code identifies the labeler, product, and package size.
- Price Trends: Prices for Pregabalin tend to increase in January and July.
- Generic Competition: Increased availability of generics can reduce brand-name prices.
- Economic Factors: Inflation and economic conditions impact drug prices.
FAQs
Q: What does the NDC code 69367-0362 represent?
A: The NDC code 69367-0362 represents a specific formulation and packaging of Pregabalin, manufactured and distributed by Westminster Pharmaceuticals, LLC.
Q: When are the most significant price increases for prescription drugs?
A: The most significant price increases for prescription drugs typically occur in January and July of each year.
Q: How does generic competition affect brand-name drug prices?
A: Generic competition can significantly reduce the market share and pricing power of brand-name drugs, leading to lower prices for the brand-name versions.
Q: What economic factors influence drug prices?
A: General inflation rates and broader economic conditions can influence drug price increases.
Q: Can we predict exact price increases for Pregabalin?
A: While exact price increases are difficult to predict, historical trends suggest that prices will likely increase by 5-10% in January and July, influenced by market and economic factors.
